This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The relationship is simple—higher cholesterol for longer increases your risk of coronaryarterydisease 4. The best cholesterol value in the standard cholesterol panel to evaluate the risk of coronaryarterydisease is your Non-HDL. 6, 2017 7 JACC: CardiovascularImaging May 2015, 8 (5) 579-596;
Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal CardiovascularImaging. With Plaque Features Associated with False Positives.
Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascularimaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronaryarterydisease.
a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal CardiovascularImaging. 1 Heart disease is the leading cause of death for both men and women.²
The reason: They were accumulating plaque in their coronaryarteries much earlier than their peers. You can’t have a heart attack if you don’t have plaque in your coronaryarteries. And plaque in your coronaryarteries is the result of exposure to risk factors over time.
Christian Tesche (Division of CardiovascularImaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).
The Cleerly ISCHEMIA software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronaryarterydisease," said James P. "The in European Association of CardiovascularImaging: Late Breaking Clinical Research and Trials.
Therefore, if someone presents with an event earlier than this age, they likely have been building up plaque for a considerable period prior to this. Here is what I DON’T consider as early heart disease. ” Here is what I DO consider as early heart disease. Most of the time, coronaryarterydisease will be the cause.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016178, February 1, 2024. BACKGROUND:It is not known whether there is a sex difference in the association between perivascular inflammation and plaque vulnerability. All images were analyzed at a core laboratory. plaques per patient). versus 46.9%,P=0.002
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016057, February 1, 2024. BACKGROUND:Sex-specific differences in coronary phenotypes in response to stress have not been elucidated. P=0.004), while men had a higher frequency of high-risk plaques (53.7% women and 72.3% men) were enrolled. versus 24.0%;P=0.004),
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content